BCL6 and neoplasm: The addition of Wnt inhibitors and rescue experiments further clarified that BCL6 inhibits the Wnt/β-catenin signaling pathway through direct transcriptional repression of the oncogene FZD7, thereby exerting its tumor suppressor effect in GC.